Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Viral infiltration of pancreatic islets in patients with COVID-19
Charlotte Steenblock, Stefanie Richter, Ilona Berger, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 166

Showing 1-25 of 166 citing articles:

COVID-19 and metabolic disease: mechanisms and clinical management
Charlotte Steenblock, Peter E. H. Schwarz, Barbara Ludwig, et al.
The Lancet Diabetes & Endocrinology (2021) Vol. 9, Iss. 11, pp. 786-798
Open Access | Times Cited: 206
Impact of COVID-19 on the Endocrine System: A Mini-review
Sophie Clarke, Ali Abbara, Waljit S. Dhillo
Endocrinology (2021) Vol. 163, Iss. 1
Open Access | Times Cited: 100
The Role of Viral Infections in the Onset of Autoimmune Diseases
Bhargavi Sundaresan, Fatemeh Shirafkan, Kevin Ripperger, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 782-782
Open Access | Times Cited: 78
Diabetes and COVID-19; A Bidirectional Interplay
Paraskevi Kazakou, Vaia Lambadiari, Ignatios Ikonomidis, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 64
COVID-19 and thyroid function: What do we know so far?
Camila Lüdke Rossetti, Juliana Cazarin, Fábio Hecht, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 55
The pathogenesis of coronavirus-19 disease
Alain Borczuk, Rhonda K. Yantiss
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 54
New-Onset Diabetes Mellitus, Hypertension, Dyslipidaemia as Sequelae of COVID-19 Infection—Systematic Review
Marysia Wrona, Damian Skrypnik
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 20, pp. 13280-13280
Open Access | Times Cited: 53
First report from the German COVID-19 autopsy registry
Saskia von Stillfried, Roman D. Bülow, Rainer Röhrig, et al.
The Lancet Regional Health - Europe (2022) Vol. 15, pp. 100330-100330
Open Access | Times Cited: 50
Diabetes and COVID-19: Short- and Long-Term Consequences
Charlotte Steenblock, Mohamed Hassanein, Emran G. Khan, et al.
Hormone and Metabolic Research (2022) Vol. 54, Iss. 08, pp. 503-509
Open Access | Times Cited: 50
Programmed cell death: the pathways to severe COVID-19?
Stefanie M. Bader, James P. Cooney, Marc Pellegrini, et al.
Biochemical Journal (2022) Vol. 479, Iss. 5, pp. 609-628
Open Access | Times Cited: 49
Limited extent and consequences of pancreatic SARS-CoV-2 infection
Verena van der Heide, Sonia Jangra, Phillip Cohen, et al.
Cell Reports (2022) Vol. 38, Iss. 11, pp. 110508-110508
Open Access | Times Cited: 48
Risk of new‐onset type 2 diabetes in 600 055 people after COVID‐19: A cohort study
Morgan Birabaharan, David C. Kaelber, Jeremy Pettus, et al.
Diabetes Obesity and Metabolism (2022) Vol. 24, Iss. 6, pp. 1176-1179
Open Access | Times Cited: 43
Mechanisms of COVID-19 pathogenesis in diabetes
Chandrakala Aluganti Narasimhulu, Dinender K. Singla
AJP Heart and Circulatory Physiology (2022) Vol. 323, Iss. 3, pp. H403-H420
Open Access | Times Cited: 42
COVID-19-related hyperglycemia is associated with infection of hepatocytes and stimulation of gluconeogenesis
Ester A. Barreto, Amanda Stephane Cruz dos Passos, Flávio P. Veras, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 21
Open Access | Times Cited: 34
COVID-19 as a Trigger for Type 1 Diabetes
Yichen Wang, Hui Guo, Gongquan Wang, et al.
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 108, Iss. 9, pp. 2176-2183
Closed Access | Times Cited: 29
Pathogenesis and Mechanisms of SARS-CoV-2 Infection in the Intestine, Liver, and Pancreas
Zaid Khreefa, Mallory T. Barbier, Ali Rıza Köksal, et al.
Cells (2023) Vol. 12, Iss. 2, pp. 262-262
Open Access | Times Cited: 25
New-Onset Diabetes After COVID-19
Sun H. Kim, Ipsa Arora, Daniel S. Hsia, et al.
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 108, Iss. 11, pp. e1164-e1174
Closed Access | Times Cited: 25
Infection with SARS-CoV-2 can cause pancreatic impairment
Wei Deng, Linlin Bao, Zhiqi Song, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 9
Necroptosis does not drive disease pathogenesis in a mouse infective model of SARS-CoV-2 in vivo
Stefanie M. Bader, James P. Cooney, Reet Bhandari, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Impact of Delta SARS-CoV-2 Infection on Glucose Metabolism: Insights on Host Metabolism and Virus Crosstalk in a Feline Model
Matthew T. Rochowski, Kaushalya Jayathilake, John-Michael Balcerak, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 295-295
Open Access | Times Cited: 7
Indirect and Direct Effects of SARS-CoV-2 on Human Pancreatic Islets
Moufida Ben Nasr, Francesca D’Addio, Laura Montefusco, et al.
Diabetes (2022) Vol. 71, Iss. 7, pp. 1579-1590
Open Access | Times Cited: 35
Coronavirus disease 2019 (COVID‐19) update: From metabolic reprogramming to immunometabolism
Mohammad Rudiansyah, Saade Abdalkareem Jasim, Zeinab Gol Mohammad pour, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 10, pp. 4611-4627
Open Access | Times Cited: 34
Signaling pathways and intervention for therapy of type 2 diabetes mellitus
Rong Cao, Huimin Tian, Yu Zhang, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 20
Mechanisms and clinical relevance of the bidirectional relationship of viral infections with metabolic diseases
Nikolaos Perakakis, Hani Harb, Benjamin G. Hale, et al.
The Lancet Diabetes & Endocrinology (2023) Vol. 11, Iss. 9, pp. 675-693
Open Access | Times Cited: 18
SARS-CoV-2 infection and its effects on the endocrine system
Charlotte Steenblock, Nicole Toepfner, Felix Beuschlein, et al.
Best Practice & Research Clinical Endocrinology & Metabolism (2023) Vol. 37, Iss. 4, pp. 101761-101761
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top